Denosumab for Prevention of Fractures in Postmenopausal Women with OsteoporosisSteven R. Cummings, Claus Christiansen, Pierre Delmas et al.|New England Journal of Medicine|2009Cited by 3.4k
Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapyJean‐Marc Kaufman, B. Mitlak, Stefan Goemaere et al.|Osteoporosis International|2004Cited by 320
Continued Beneficial Effects of Burosumab in Adults with X-Linked Hypophosphatemia: Results from a 24-Week Treatment Continuation Period After a 24-Week Double-Blind Placebo-Controlled PeriodAnthony A. Portale, Karl Insogna, Thomas O. Carpenter et al.|Calcified Tissue International|2019Cited by 160